Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer

Value in Health

Volumn 15, Issue 1, 2012, Pages 72-80

  Sail, Kavita R ^a,b   Franzini, Luisa ^a   Lairson, David R ^a   Du, Xianglin L ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b McKesson Specialty Health   (United States)

Author keywords

chemotherapy; effectiveness; phase of care; treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; FEMALE; GERIATRIC PATIENT; HEALTH CARE COST; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMORBIDITY; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MEDICARE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84856023478     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.10.004     Document Type: Article

References (38)

1. W.E. Barlow, S.H. Taplin, C.K. Yoshida Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer J Natl Cancer Inst 93 2001 447 455 (Pubitemid 32266537)
2. C.E. Desch, L.T. Penberthy, B.E. Hillner A sociodemographic and economic comparison of breast reconstruction, mastectomy, and conservative surgery Surgery 125 1999 441 447 (Pubitemid 29166378)
3. B.H. Fireman, C.P. Quesenberry, C.P. Somkin Cost of care for cancer in a health maintenance organization Health Care Financ Rev 18 1997 51 76 (Pubitemid 27516400)
4. G.F. Riley, A.L. Potosky, J.D. Lubitz, L.G. Kessler Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis Med Care 33 1995 828 841
5. J.L. Warren, M.L. Brown, M.P. Fay Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings J Clin Oncol 20 2002 307 316 (Pubitemid 34032626)
6. American Cancer Society Cancer Facts and Figures 2008 2008 American Cancer Society
7. N. Oestreicher, S.D. Ramsey, J.S. McCune The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma Cancer 104 10 2005 2054 2062 (Pubitemid 41579950)
8. K.R. Yabroff, E.B. Lamont, A. Mariotto Cost of care for elderly cancer patients in the United States J Natl Cancer Inst 100 2008 630 641
9. Early Breast Cancer Trialists' Collaborative Group Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 352 1998 930 942
10. Early Breast Cancer Trialists' Collaborative Group Multi-agent chemotherapy for early breast cancer Cochrane Database Syst Rev 2002 CD000487
11. S. Burdette-Radoux, H.B. Muss Adjuvant chemotherapy in the elderly: whom to treat, what regimen? Oncologist 11 2006 234 242
12. A. DeMichele, M. Putt, Y. Zhang Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients Cancer 97 2003 2150 2159 (Pubitemid 36444055)
13. X.L. Du, D.V. Jones, D. Zhang Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women J Gerontol A Biol Sci Med Sci 60 2005 1137 1144 (Pubitemid 41384482)
14. E.B. Elkin, A. Hurria, N. Mitra Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort J Clin Oncol 24 2006 2757 2764 (Pubitemid 46630573)
15. H.B. Muss The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women Cancer 74 7, Suppl. 1994 2165 2171 (Pubitemid 24304390)
16. H.B. Muss Chemotherapy of breast cancer in the older patient Semin Oncol 22 1, Suppl. 1 1995 14 16
17. H.B. Muss, S. Woolf, D. Berry Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer JAMA 293 2005 1073 1081 (Pubitemid 40300281)
18. NIH Consensus Conference Adjuvant chemotherapy for breast cancer JAMA 254 1985 3461 3463
19. NIH Consensus Conference Adjuvant chemotherapy for breast cancer JAMA 265 1991 391 395
20. C.B. Begg, J.L. Cohen, J. Ellerton Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group Cancer Clin Trials 3 1980 369 374 (Pubitemid 11201111)
21. S. Greenfield, D.M. Blanco, R.M. Elashoff, P.A. Ganz Patterns of care related to age of breast cancer patients JAMA 257 1987 2766 2770 (Pubitemid 17066520)
22. C.P. Hunter, R.W. Frelick, A.R. Feldman Selection factors in clinical trials: results from the community clinical oncology program physician's patient log Cancer Treat Rep 71 1987 559 565 (Pubitemid 17090253)
23. V. Mor, S. Masterson-Allen, R.J. Goldberg Relationship between age at diagnosis and treatments received by cancer patients J Am Geriatr Soc 33 1985 585 589 (Pubitemid 16238707)
24. C.E. Holmes, H.B. Muss Diagnosis and treatment of breast cancer in the elderly CA Cancer J Clin 53 2003 227 244 (Pubitemid 37045791)
25. S. Rao, J. Kubisiak, D. Gilden Cost of illness associated with metastatic breast cancer Breast Cancer Res Treat 83 2004 25 32 (Pubitemid 38141890)
26. X.L. Du, C.R. Key, L. Dickie External validation of Medicare claims for breast cancer chemotherapy compared with medical chart reviews Med Care 44 2006 124 131 (Pubitemid 43755463)
27. W. Du, M.S. Simon Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit Breast Cancer Res Treat 91 2005 243 248 (Pubitemid 40896570)
28. T.R. Halfhill Tom's Inflation Calculator v7.5.2 http://www.halfhill.com/ inflation.html [Accessed September 30, 2010]
29. M.R. Gold, J.E. Siegel, L.B. Russell Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York, NY
30. P.R. Rosenbaum, D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
31. R.B. D'Agostino Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281 (Pubitemid 28466823)
32. Stata Corporation. Intercooled Stata version 9.0. College Station, TX: Stata Corporation.
33. SAS Institute Inc. SAS® 9.2. SAS Institute Inc, Cary, North Carolina, USA.
34. G. Bonadonna, E. Brusamolino, P. Valagussa Combination chemotherapy as an adjuvant treatment in operable breast cancer N Engl J Med 294 1976 405 410
35. X.L. Du, C.R. Key, C. Osborne Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer Ann Intern Med 138 2003 90 97 (Pubitemid 36222495)
36. X.L. Du, C. Osborne, J.S. Goodwin Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer J Clin Oncol 20 2002 4636 4642 (Pubitemid 36025279)
37. L.C. Harlan, J. Abrams, J.L. Warren Adjuvant therapy for breast cancer: practice patterns of community physicians J Clin Oncol 20 2002 1809 1817 (Pubitemid 34273270)
38. R. Yancik, M.N. Wesley, L.A. Ries Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older JAMA 285 2001 885 892 (Pubitemid 32171549)